MST1 and breast cancer: Flow cytometry analyses of similar sized mammary tumors showed significantly fewer Lin−CD29HiCD24+ BCSCs in the RON signaling-deficient MMTV-Ron Hgfl−/− tumors compared with MMTV-Ron Hgfl+/+ controls (Figure 1A and 1B).